Drug intelligence / Profile preview

prednisone + aspirin

Development stage
Unknown
Lead developer
Bayer
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Oral, Rectal
01

Overview

Prednisone + aspirin is a combination of two pharmaceutical drugs, each with distinct mechanisms of action. Prednisone is a synthetic corticosteroid that suppresses inflammation and modulates immune responses by inhibiting multiple inflammatory pathways, including the suppression of pro-inflammatory gene expression via glucocorticoid receptor activation. Aspirin (acetylsalicylic acid) is a nonsteroidal anti-inflammatory drug (NSAID) that irreversibly inhibits cyclooxygenase enzymes (COX-1 and COX-2), leading to reduced synthesis of prostaglandins and thromboxanes, which mediate pain, fever, inflammation, and platelet aggregation. This combination may be used in certain inflammatory or autoimmune conditions but carries an increased risk for gastrointestinal side effects such as bleeding or ulceration due to additive effects on the GI mucosa[2][4]. The use of both drugs together should be carefully monitored by healthcare professionals.

02

Targets

GR (Glucocorticoid receptor)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on prednisone + aspirin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on prednisone + aspirin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call